• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国天花疫苗接种计划的安全性监测:免疫实践咨询委员会与武装部队流行病学委员会联合天花疫苗安全工作组报告

Monitoring the safety of a smallpox vaccination program in the United States: report of the joint Smallpox Vaccine Safety Working Group of the advisory committee on immunization practices and the Armed Forces Epidemiological Board.

作者信息

Neff John, Modlin John, Birkhead Guthrie S, Poland Gregory, Robertson Rose Marie, Sepkowitz Kent, Yancy Clyde, Gardner Pierce, Gray Gregory C, Maurer Toby, Siegel Jane, Guerra Fernando A, Berger Tim, Flanders W Dana, Shope Robert

机构信息

Children's Hospital and Regional Medical Center, Seattle, Washington, USA.

出版信息

Clin Infect Dis. 2008 Mar 15;46 Suppl 3:S258-70. doi: 10.1086/524749.

DOI:10.1086/524749
PMID:18284367
Abstract

In December 2002, the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices and the Department of Defense Armed Forces Epidemiological Board formed a joint Smallpox Vaccine Safety Working Group (SVS WG) to provide independent safety oversight for smallpox vaccination safety-monitoring systems. From January 2003 through June 2004, the SVS WG reviewed individual and aggregate safety data on postvaccination adverse events. Serious adverse events were rare because of careful education, prevaccination screening, and strict attention to vaccination-site management. Recent vaccinees safely cared for high-risk patients, adhering to recommended site care. Human immunodeficiency virus-infected individuals without severe immunosuppression had uncomplicated vaccination reactions. Epidemiological studies supported a causal relationship between myocarditis and/or pericarditis and smallpox vaccination. Data supported neutrality regarding hypothesized causal associations between vaccination and dilated cardiomyopathy or ischemic cardiac disease. The SVS WG concurs with recommendations to defer from vaccination any person with >/=3 ischemic cardiac disease risk factors.

摘要

2002年12月,疾病控制与预防中心免疫实践咨询委员会和国防部武装部队流行病学委员会成立了一个联合天花疫苗安全工作组(SVS WG),为天花疫苗接种安全监测系统提供独立的安全监督。从2003年1月到2004年6月,SVS WG审查了接种后不良事件的个体和汇总安全数据。由于进行了仔细的教育、接种前筛查以及对疫苗接种部位管理的严格关注,严重不良事件很少见。近期接种疫苗者安全护理高危患者,遵循推荐的部位护理方法。没有严重免疫抑制的人类免疫缺陷病毒感染者接种疫苗后的反应并不复杂。流行病学研究支持心肌炎和/或心包炎与天花疫苗接种之间存在因果关系。数据支持在疫苗接种与扩张型心肌病或缺血性心脏病之间假设的因果关联方面保持中立。SVS WG同意以下建议:对于有≥3个缺血性心脏病风险因素的任何人,推迟接种疫苗。

相似文献

1
Monitoring the safety of a smallpox vaccination program in the United States: report of the joint Smallpox Vaccine Safety Working Group of the advisory committee on immunization practices and the Armed Forces Epidemiological Board.美国天花疫苗接种计划的安全性监测:免疫实践咨询委员会与武装部队流行病学委员会联合天花疫苗安全工作组报告
Clin Infect Dis. 2008 Mar 15;46 Suppl 3:S258-70. doi: 10.1086/524749.
2
A process for sentinel case review to assess causal relationships between smallpox vaccination and adverse outcomes, 2003-2004.2003 - 2004年用于评估天花疫苗接种与不良后果之间因果关系的哨点病例审查流程。
Clin Infect Dis. 2008 Mar 15;46 Suppl 3:S271-93. doi: 10.1086/524750.
3
Update: cardiac-related events during the civilian smallpox vaccination program--United States, 2003.更新:2003年美国平民天花疫苗接种计划期间的心脏相关事件
MMWR Morb Mortal Wkly Rep. 2003 May 30;52(21):492-6.
4
Myocarditis, pericarditis, and dilated cardiomyopathy after smallpox vaccination among civilians in the United States, January-October 2003.2003年1月至10月美国平民接种天花疫苗后发生的心肌炎、心包炎和扩张型心肌病。
Clin Infect Dis. 2008 Mar 15;46 Suppl 3:S242-50. doi: 10.1086/524747.
5
Economics of cardiac adverse events after smallpox vaccination: lessons from the 2003 US Vaccination Program.天花疫苗接种后心脏不良事件的经济学分析:来自2003年美国疫苗接种计划的经验教训。
Clin Infect Dis. 2008 Mar 15;46 Suppl 3:S168-78. doi: 10.1086/524380.
6
US Civilian Smallpox Preparedness and Response Program, 2003.美国平民天花防范与应对计划,2003年
Clin Infect Dis. 2008 Mar 15;46 Suppl 3:S157-67. doi: 10.1086/524751.
7
Supplemental recommendations on adverse events following smallpox vaccine in the pre-event vaccination program: recommendations of the Advisory Committee on Immunization Practices.事件前疫苗接种计划中天花疫苗接种后不良事件的补充建议:免疫实践咨询委员会的建议
MMWR Morb Mortal Wkly Rep. 2003 Apr 4;52(13):282-4.
8
Update: adverse events following smallpox vaccination--United States, 2003.更新:2003年美国天花疫苗接种后的不良事件
MMWR Morb Mortal Wkly Rep. 2003 Apr 4;52(13):278-82.
9
Update: cardiac and other adverse events following civilian smallpox vaccination--United States, 2003.更新:2003年美国平民接种天花疫苗后的心脏及其他不良事件
MMWR Morb Mortal Wkly Rep. 2003 Jul 11;52(27):639-42.
10
Update on adverse events following civilian smallpox vaccination--United States, 2003.2003年美国平民天花疫苗接种后不良事件的最新情况
MMWR Morb Mortal Wkly Rep. 2003 Apr 11;52(14):313-5.

引用本文的文献

1
Construction of a recombinant vaccine expressing Nipah virus glycoprotein using the replicative and highly attenuated vaccinia virus strain LC16m8.利用复制性和高度减毒的痘苗病毒株 LC16m8 构建表达尼帕病毒糖蛋白的重组疫苗。
PLoS Negl Trop Dis. 2023 Dec 15;17(12):e0011851. doi: 10.1371/journal.pntd.0011851. eCollection 2023 Dec.
2
Potential use of cidofovir, brincidofovir, and tecovirimat drugs in fighting monkeypox infection: recent trends and advancements.西多福韦、溴夫定和特考韦瑞玛特药物在对抗猴痘感染中的潜在用途:最新趋势和进展。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Apr;397(4):2055-2065. doi: 10.1007/s00210-023-02769-y. Epub 2023 Oct 14.
3
Circulating Spike Protein Detected in Post-COVID-19 mRNA Vaccine Myocarditis.
新冠病毒 mRNA 疫苗心肌炎患者循环 Spike 蛋白的检测。
Circulation. 2023 Mar 14;147(11):867-876. doi: 10.1161/CIRCULATIONAHA.122.061025. Epub 2023 Jan 4.
4
Prevention of monkeypox with vaccines: a rapid review.疫苗预防猴痘:快速综述。
Lancet Infect Dis. 2022 Dec;22(12):e349-e358. doi: 10.1016/S1473-3099(22)00574-6. Epub 2022 Sep 15.
5
Current Challenges in Vaccinology.疫苗学的当前挑战。
Front Immunol. 2020 Jun 25;11:1181. doi: 10.3389/fimmu.2020.01181. eCollection 2020.
6
Human Monkeypox: Epidemiologic and Clinical Characteristics, Diagnosis, and Prevention.人类猴痘:流行病学和临床特征、诊断和预防。
Infect Dis Clin North Am. 2019 Dec;33(4):1027-1043. doi: 10.1016/j.idc.2019.03.001. Epub 2019 Apr 11.
7
Safety and Immunogenicity of a 2-Dose Heterologous Vaccination Regimen With Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: 12-Month Data From a Phase 1 Randomized Clinical Trial in Uganda and Tanzania.两剂次 Ad26.ZEBOV 和 MVA-BN-Filo 埃博拉疫苗异源接种方案的安全性和免疫原性:乌干达和坦桑尼亚的 1 期随机临床试验 12 个月数据
J Infect Dis. 2019 Jun 5;220(1):46-56. doi: 10.1093/infdis/jiz070.
8
Cardiac safety of Modified Vaccinia Ankara for vaccination against smallpox in a young, healthy study population.在年轻健康的研究人群中,用于天花疫苗接种的改良安卡拉痘苗病毒的心脏安全性。
PLoS One. 2015 Apr 16;10(4):e0122653. doi: 10.1371/journal.pone.0122653. eCollection 2015.
9
Ischemic cardiac events and other adverse events following ACAM2000(®) smallpox vaccine in the Vaccine Adverse Event Reporting System.疫苗不良事件报告系统中ACAM2000(®)天花疫苗接种后的缺血性心脏事件及其他不良事件。
Vaccine. 2014 Aug 20;32(37):4758-65. doi: 10.1016/j.vaccine.2014.06.034. Epub 2014 Jun 18.
10
Unintentional transfer of vaccinia virus associated with smallpox vaccines: ACAM2000(®) compared with Dryvax(®).意外接种牛痘病毒与天花疫苗相关:ACAM2000(®)与 Dryvax(®)比较。
Hum Vaccin Immunother. 2013 Jul;9(7):1489-96. doi: 10.4161/hv.24319. Epub 2013 Apr 9.